Pulmonx Corp - COMMON STOCK (LUNG)

Historical Holders from Q4 2020 to Q2 2025

Symbol
LUNG on Nasdaq
CUSIP
745848101
Type / Class
Equity / COMMON STOCK
Shares outstanding
40.4M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
36.3M
Holdings value
$93.9M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
113
Number of buys
58
Number of sells
-59
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COMMON STOCK (LUNG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 13.61% $36.4M 5.41M PRIMECAP MANAGEMENT CO/CA/ Mar 31, 2025
MORGAN STANLEY 8.5% +12.5% $22.8M $2.86M 3.39M +14.4% Morgan Stanley Mar 31, 2025
BlackRock, Inc. 6.8% $18.1M 2.69M BlackRock, Inc. Mar 31, 2025
FMR LLC 5.4% -47.3% $3.68M -$3.52M 2.18M -48.8% FMR LLC Aug 29, 2025

Institutional Holders of Pulmonx Corp - COMMON STOCK (LUNG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 36.3M $93.9M -$4.6M $2.59 113
2025 Q1 36.2M $243M +$1.66M $6.73 114
2024 Q4 35.9M $244M +$2.67M $6.79 117
2024 Q3 35.4M $293M +$6.9M $8.29 112
2024 Q2 34.7M $220M +$16.5M $6.34 108
2024 Q1 3.53M $32.7M -$14.2M $9.27 9
2023 Q4 15.1K $193K $12.75 1
2023 Q3 101 $2K -$2.38M $19.80 2
2023 Q2 33.5M $439M -$14.2M $13.11 111
2023 Q1 34.7M $388M +$28.5M $11.18 100
2022 Q4 33.7M $284M -$83.3M $8.43 108
2022 Q3 33M $550M -$341K $16.66 96
2022 Q2 35.3M $520M -$7.93M $14.72 99
2022 Q1 34.4M $852M +$57.2M $24.81 101
2021 Q4 31.8M $1.02B +$25.8M $32.07 105
2021 Q3 31.6M $1.14B +$204M $35.98 117
2021 Q2 25.9M $1.14B +$184M $44.12 114
2021 Q1 21.6M $988M +$116M $45.74 109
2020 Q4 18.4M $1.26B +$1.02B $69.02 99